Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction.
Del Buono MG, Moroni F, Montone RA, Azzalini L, Sanna T, Abbate A.
Curr Cardiol Rep. 2022 Oct;24(10):1505-1515. doi: 10.1007/s11886-022-01766-6. Epub 2022 Aug 16.
Accurate Classification of Non-ischemic Cardiomyopathy.
Wang Y, Jia H, Song J.
Curr Cardiol Rep. 2023 Oct;25(10):1299-1317. doi: 10.1007/s11886-023-01944-0. Epub 2023 Sep 15.
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How.
Liga R, Colli A, Taggart DP, Boden WE, De Caterina R.
J Am Heart Assoc. 2023 Mar 21;12(6):e026943. doi: 10.1161/JAHA.122.026943. Epub 2023 Mar 9.
Septic Cardiomyopathy.
Beesley SJ, Weber G, Sarge T, Nikravan S, Grissom CK, Lanspa MJ, Shahul S, Brown SM.
Crit Care Med. 2018 Apr;46(4):625-634. doi: 10.1097/CCM.0000000000002851.
Relief of Ischemia in Ischemic Cardiomyopathy.
Moroni F, Gertz Z, Azzalini L.
Curr Cardiol Rep. 2021 Jun 3;23(7):80. doi: 10.1007/s11886-021-01520-4.
Gender Differences in Ischemic Cardiomyopathy.
Divoky L, Maran A, Ramu B.
Curr Atheroscler Rep. 2018 Sep 3;20(10):50. doi: 10.1007/s11883-018-0750-x.
Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
Bansal SS, Ismahil MA, Goel M, Zhou G, Rokosh G, Hamid T, Prabhu SD.
Circulation. 2019 Jan 8;139(2):206-221. doi: 10.1161/CIRCULATIONAHA.118.036065.
Mitochondrial disorder and treatment of ischemic cardiomyopathy: Potential and advantages of Chinese herbal medicine.
Chang X, Liu J, Wang Y, Guan X, Liu R.
Biomed Pharmacother. 2023 Mar;159:114171. doi: 10.1016/j.biopha.2022.114171. Epub 2023 Jan 13.
Ischemic cardiomyopathy.
Burch GE, Tsui CY, Harb JM.
Am Heart J. 1972 Mar;83(3):340-50. doi: 10.1016/0002-8703(72)90435-8.
Q waves in ischemic cardiomyopathy.
Ródenas-Alesina E, Jordán P, Herrador L, Espinet-Coll C, Pizzi MN, Romero-Farina G, Aguadé-Bruix S, Ferreira-González I.
Int J Cardiovasc Imaging. 2021 Jun;37(6):2085-2092. doi: 10.1007/s10554-021-02172-9. Epub 2021 Jan 31.
